Prospective evaluation of the relationship between platelet–leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes
- 1 February 2004
- journal article
- clinical trial
- Published by Taylor & Francis Ltd in Platelets
- Vol. 15 (1), 9-14
- https://doi.org/10.1080/09537100310001644006
Abstract
Platelet–leukocyte conjugates are increased in patients with coronary artery disease but the relationship between conjugate formation and myocardial ischemic outcome is unknown. We prospectively evaluated the relationship between conjugate formation and the development of recurrent myocardial ischemia in patients with acute coronary syndromes (ACS). Platelet–leukocyte conjugate formation (induced by thrombin receptor activating peptide (TRAP)) and platelet aggregation (induced by ADP and arachidonic acid) were assessed in 30 patients with unstable angina or non-ST elevation myocardial infarction. All patients were treated with β-blockers, aspirin, heparin, and GPIIb–IIIa antagonists and were followed for in-hospital recurrent myocardial ischemia. Troponin I and C-reactive protein (CRP) were also measured. Seven patients (23%) experienced recurrent ischemia. Platelet–neutrophil conjugates were greater in ischemic patients (59 ± 9 and 36 ± 4%, P = 0.007, for + ischemia and −ischemia, respectively). Platelet aggregation did not differ between ischemic and nonischemic patients, and there was no significant relationship between aspirin resistance and ischemic outcome. Troponin I was greater in patients who developed recurrent ischemia (3.04 ± 1.73 vs. 0.70 ± 0.21 ng/ml, P = 0.03, for +ischemia and −ischemia, respectively) but CRP was not. TRAP-induced platelet–neutrophil conjugate formation was an independent predictor of ischemic outcome (OR 1.07, 95% CI 1.00–1.15, for each 1% increase in conjugate formation). Receiver operator characteristic analysis showed platelet–neutrophil conjugates to have good ability to discriminate between ischemic and nonischemic patients (AUC of 0.84, Pin vivo ischemic risk in ACS patients.Keywords
This publication has 21 references indexed in Scilit:
- Circulating Monocyte-Platelet Aggregates Are a More Sensitive Marker of In Vivo Platelet Activation Than Platelet Surface P-SelectinCirculation, 2001
- Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysisThe Lancet, 2001
- C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A SubstudyJournal of the American College of Cardiology, 1998
- Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment.JCI Insight, 1997
- Induction of Cytokine Expression in Leukocytes by Binding of Thrombin-Stimulated PlateletsCirculation, 1997
- Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1996
- Increased Neutrophil-Platelet Adhesion in Patients With Unstable AnginaCirculation, 1996
- Activated platelets signal chemokine synthesis by human monocytes.JCI Insight, 1996
- Blood platelet count and function are related to total and cardiovascular death in apparently healthy men.Circulation, 1991
- Platelet Hyperreactivity and Prognosis in Survivors of Myocardial InfarctionNew England Journal of Medicine, 1990